AstraZeneca PLC
AZN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000901832
In the last 90 days, AstraZeneca PLC insiders filed 1 open-market purchase and 0 sales; 1,509 institutions reported holding it in 13F filings for Q2 2026, worth $207.5B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by AstraZeneca PLC insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $3.25K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$3.25K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for AstraZeneca PLC, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sharma Mani | See Remarks | 19,289 | Sep 11, 2026 | 6 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 (view filing)4:05 PM ET | Aug 8 | 34 daysLate | Sharma ManiSee Remarks | PPurchase | +20.23 | $160.57 | +$3.25K | +0.1%19.3K after | |
| May 22, 2026 (view filing) | May 20 | 2 days | Sharma ManiSee Remarks | SSale | −11.9K | $185.78 | −$2.21M | −38.2%19.3K after |